KEYNOTE-942: DMFS findings of a personalized mRNA vaccine in melanoma

A personalized mRNA vaccine with pembrolizumab in melanomaSee more

Developing personalized therapeutic cancer vaccines for melanomaSee more

The future of personalized, neoantigen cancer vaccinesSee more

mRNA-4157, a novel mRNA vaccine, with pembrolizumab in melanomaSee more

New study finds mRNA vaccine helps battle against melanomaSee more

Can personalized mRNA vaccines be applicable in lung cancer?See more

Melanoma study finds mRNA vaccine combined with standard treatment could reduce recurrenceSee more

Unanswered questions in the use of mRNA-based personalized cancer vaccinesSee more

Highlights in melanoma at AACR 2023See more

First ‘personalised’ melanoma skin cancer vaccine trial under way in UK | BBC NewsSee more

MD Anderson to test personalized mRNA vaccines as cancer treatmentSee more

Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrenceSee more

New melanoma vaccine could cut risk of cancer recurrenceSee more

Moderna to develop a personalized cancer vaccine with MerckSee more

Vaccine-immunotherapy combo for high risk melanoma: New data on distant metastasis-free survivalSee more

Cancer Vaccine: Moderna and Merck's Melanoma vaccine moves on to third trial phaseSee more

Highlighting the advantages of neoantigen mRNA vaccines in melanomaSee more

New cancer treatment vaccine hailed as major melanoma breakthrough | ABC NewsSee more

Dr. Jeffrey Weber Discusses Promising Results of mRNA-Based Melanoma Vaccine TrialSee more